300406 九强生物
已收盘 08-12 15:00:00
资讯
新帖
简况
股市必读:九强生物新发布《关于副董事长、总经理离任的公告》
证券之星 · 08-03
股市必读:九强生物新发布《关于副董事长、总经理离任的公告》
股市必读:新发布《北京九强生物技术股份有限公司公开发行可转换公司债券第四次临时受托管理事务报告(2026年度)》
证券之星 · 07-31
股市必读:新发布《北京九强生物技术股份有限公司公开发行可转换公司债券第四次临时受托管理事务报告(2026年度)》
九强生物(300406)披露限制性股票回购注销完成公告,7月30日股价上涨0.53%
证券之星 · 07-30
九强生物(300406)披露限制性股票回购注销完成公告,7月30日股价上涨0.53%
九强生物(300406)披露部分限制性股票回购注销完成公告,7月24日股价下跌2.38%
证券之星 · 07-24
九强生物(300406)披露部分限制性股票回购注销完成公告,7月24日股价下跌2.38%
九强生物(300406)披露取得两项医疗器械注册证书公告,7月9日股价下跌1.41%
证券之星 · 07-09
九强生物(300406)披露取得两项医疗器械注册证书公告,7月9日股价下跌1.41%
九强生物最新公告:取得两项医疗器械注册证书
证券之星 · 07-09
九强生物最新公告:取得两项医疗器械注册证书
九强生物(300406)披露2025年度可转换公司债券受托管理事务报告,6月29日股价上涨4.07%
证券之星 · 06-29
九强生物(300406)披露2025年度可转换公司债券受托管理事务报告,6月29日股价上涨4.07%
九强生物(300406)披露取得医疗器械注册证书公告,6月23日股价上涨2.39%
证券之星 · 06-23
九强生物(300406)披露取得医疗器械注册证书公告,6月23日股价上涨2.39%
九强生物(300406.SZ)取得一项医疗器械注册证书
智通财经 · 06-23
九强生物(300406.SZ)取得一项医疗器械注册证书
每周股票复盘:九强生物(300406)股东终止转让5%股份
证券之星 · 06-21
每周股票复盘:九强生物(300406)股东终止转让5%股份
九强生物(300406)披露股东终止协议转让部分股份公告,6月18日股价上涨0.35%
证券之星 · 06-18
九强生物(300406)披露股东终止协议转让部分股份公告,6月18日股价上涨0.35%
九强生物(300406.SZ):两款产品取得医疗器械注册证书
智通财经 · 06-08
九强生物(300406.SZ):两款产品取得医疗器械注册证书
九强生物(300406.SZ):全自动化学发光免疫分析仪取得医疗器械注册证书
智通财经 · 06-04
九强生物(300406.SZ):全自动化学发光免疫分析仪取得医疗器械注册证书
九强生物(300406.SZ):甲状腺素结合力测定试剂盒取得医疗器械注册证书
智通财经 · 06-03
九强生物(300406.SZ):甲状腺素结合力测定试剂盒取得医疗器械注册证书
九强生物(300406)披露“九强转债”恢复转股提示性公告,5月28日股价上涨0.16%
证券之星 · 05-28
九强生物(300406)披露“九强转债”恢复转股提示性公告,5月28日股价上涨0.16%
九强生物(300406)披露可转债转股价格调整公告,5月27日股价下跌1.88%
证券之星 · 05-27
九强生物(300406)披露可转债转股价格调整公告,5月27日股价下跌1.88%
九强生物:公司2025年年度权益分派股权登记日为
证券之星 · 05-25
九强生物:公司2025年年度权益分派股权登记日为
股市必读:九强生物(300406)5月20日董秘有最新回复
证券之星 · 05-21
股市必读:九强生物(300406)5月20日董秘有最新回复
九强生物(300406)披露权益分派期间“九强转债”暂停转股公告,5月20日股价下跌1.08%
证券之星 · 05-20
九强生物(300406)披露权益分派期间“九强转债”暂停转股公告,5月20日股价下跌1.08%
九强生物(300406)披露2025年年度股东会决议公告,5月19日股价上涨0.46%
证券之星 · 05-19
九强生物(300406)披露2025年年度股东会决议公告,5月19日股价上涨0.46%
加载更多
公司概况
公司名称:
北京九强生物技术股份有限公司
所属行业:
医药制造业
上市日期:
2014-10-30
主营业务:
北京九强生物技术股份有限公司的主营业务是体外诊断试剂及体外诊断仪器的生产及销售。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统、液体活检系统。2025年1月14日,公司荣获“军事科学技术进步一等奖”,2025年12月6日,公司凭借高质量的信息披露水平、高效的沟通方式、优异的公共关系管理和投资者关系管理能力,荣获“金信披奖”。
发行价格:
14.32
{"stockData":{"symbol":"300406","market":"SZ","secType":"STK","nameCN":"九强生物","latestPrice":11.89,"timestamp":1786518201000,"preClose":11.83,"halted":0,"volume":3581828,"delay":0,"changeRate":0.0051,"floatShares":424000000,"shares":586000000,"eps":0.3621,"marketStatus":"已收盘","change":0.06,"latestTime":"08-12 15:00:00","open":11.86,"high":11.99,"low":11.76,"amount":42562000,"amplitude":0.0194,"askPrice":11.89,"askSize":228,"bidPrice":11.88,"bidSize":107,"shortable":0,"etf":0,"ttmEps":0.3621,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786584600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.83,"symbolType":"stock","openAndCloseTimeList":[[1786498200000,1786505400000],[1786510800000,1786518000000]],"highLimit":13.01,"lowLimit":10.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":586140466,"isCdr":false,"pbRate":1.85,"roa":"--","peRate":32.836233,"roe":"2.74%","epsLYR":0.32,"committee":0.14137,"marketValue":6969000000,"turnoverRate":0.0084,"status":0,"floatMarketCap":5045000000},"requestUrl":"/m/hq/s/300406","defaultTab":"news","newsList":[{"id":"2656348249","title":"股市必读:九强生物新发布《关于副董事长、总经理离任的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656348249","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656348249?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:48","pubTimestamp":1785692894,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,九强生物报收于11.64元,上涨2.28%,换手率1.66%,成交量7.05万手,成交额8172.76万元。当日关注点交易信息汇总:7月31日主力资金净流出694.17万元,占总成交额8.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406","BK0239","BK0012","BK0077","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800347","title":"股市必读:新发布《北京九强生物技术股份有限公司公开发行可转换公司债券第四次临时受托管理事务报告(2026年度)》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800347","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655800347?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:17","pubTimestamp":1785435431,"startTime":"0","endTime":"0","summary":"公司公告汇总北京九强生物技术股份有限公司公开发行可转换公司债券第四次临时受托管理事务报告北京九强生物技术股份有限公司因第五期限制性股票激励计划预留授予第二个解除限售期公司层面业绩考核未达标,对7名激励对象合计168,162股限制性股票进行回购注销,占注销前总股本的0.03%。回购总价为1,363,793.82元,已于2026年7月23日完成注销,公司总股本由586,308,628股减少至586,140,466股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","300406","BK0028","BK0046","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655066858","title":"九强生物(300406)披露限制性股票回购注销完成公告,7月30日股价上涨0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655066858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655066858?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:34","pubTimestamp":1785422055,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘,九强生物报收于11.38元,较前一交易日上涨0.53%,最新总市值为66.7亿元。近日,北京九强生物技术股份有限公司披露公告,因第五期限制性股票激励计划预留授予第二个解除限售期公司层面业绩考核未达标,对7名激励对象合计168,162股限制性股票进行回购注销,占注销前总股本的0.03%。回购总价为1,363,793.82元,已于2026年7月23日完成注销,公司总股本由586,308,628股减少至586,140,466股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000039958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0028","300406","BK0012","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653033900","title":"九强生物(300406)披露部分限制性股票回购注销完成公告,7月24日股价下跌2.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653033900","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653033900?lang=zh_cn&edition=full","pubTime":"2026-07-24 22:45","pubTimestamp":1784904316,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,九强生物报收于11.08元,较前一交易日下跌2.38%,最新总市值为64.96亿元。该股当日开盘11.2元,最高11.35元,最低11.07元,成交额达3239.69万元,换手率为0.68%。公告显示,因第五期限制性股票激励计划预留授予第二个解除限售期公司层面业绩考核不达标,公司回购注销7名激励对象持有的限制性股票共计168,162股,占注销前总股本的0.03%。本次回购注销已于2026年7月23日完成,公司总股本由586,308,628股减少至586,140,466股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400042533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","300406","BK0012","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650920098","title":"九强生物(300406)披露取得两项医疗器械注册证书公告,7月9日股价下跌1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650920098","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650920098?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:31","pubTimestamp":1783607470,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘,九强生物报收于11.17元,较前一交易日下跌1.41%,最新总市值为65.49亿元。该股当日开盘11.33元,最高11.44元,最低11.0元,成交额达4681.6万元,换手率为0.99%。九强生物于近日收到北京市药品监督管理局颁发的《医疗器械注册证》,产品为抗凝血酶Ⅲ测定试剂盒和骨钙素测定试剂盒,注册类别均为Ⅱ类,有效期均至2031年7月5日。实际销售情况取决于市场推广效果,目前尚无法预测其对未来业绩的具体影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406","159883","BK0077","BK0012","BK0239","09996","BK0028","BK1574","BK1583","BK1100","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650947000","title":"九强生物最新公告:取得两项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2650947000","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650947000?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:05","pubTimestamp":1783587930,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称,公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》,包括抗凝血酶Ⅲ测定试剂盒(发色底物法)和骨钙素测定试剂盒(磁微粒化学发光免疫分析法)两项产品。上述注册证的取得丰富了公司在体外诊断凝血和化学发光细分领域的产品线,有利于提升核心竞争力和市场拓展能力,但实际销售情况取决于未来市场推广效果,投资者需注意投资风险。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900029536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK1583","BK0012","BK0077","BK1100","BK0028","159883","BK1574","300406","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647784613","title":"九强生物(300406)披露2025年度可转换公司债券受托管理事务报告,6月29日股价上涨4.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647784613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647784613?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:06","pubTimestamp":1782727615,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘,九强生物报收于11.26元,较前一交易日上涨4.07%,最新总市值为66.02亿元。近日,北京九强生物技术股份有限公司发布《中国国际金融股份有限公司关于北京九强生物技术股份有限公司可转换公司债券受托管理事务报告》。2025年公司营业收入13.56亿元,同比下降18.29%;归母净利润1.90亿元,同比下降64.35%。报告期内未发生债券持有人会议事项,偿债保障措施有效执行,未触发回售条款,董事会两次决定不向下修正转股价格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900029064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0077","BK0012","BK0028","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645467832","title":"九强生物(300406)披露取得医疗器械注册证书公告,6月23日股价上涨2.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645467832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645467832?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:24","pubTimestamp":1782224667,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘,九强生物报收于11.55元,较前一交易日上涨2.39%,最新总市值为67.72亿元。九强生物于近日披露《关于取得医疗器械注册证书的公告》。公告显示,公司近日收到国家药品监督管理局颁发的《医疗器械注册证》,产品为人ABO血型反定型用红细胞试剂盒,注册证编号为国械注准20263401280,注册类别为Ⅲ类,有效期至2031年6月21日。该产品用于临床检验中的人ABO血型反定型检测,不用于血源筛查。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1583","BK0012","BK0046","BK0077","BK1574","300406","BK1100","BK0239","09996","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645688645","title":"九强生物(300406.SZ)取得一项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2645688645","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645688645?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:46","pubTimestamp":1782200812,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九强生物(300406.SZ)发布公告,公司于近日收到国家药品监督管理局颁发的《医疗器械注册证》,产品名称:人ABO血型反定型用红细胞试剂盒,该产品用于人ABO血型反定型检测,仅用于临床检验,不用于血源筛查。上述产品医疗器械注册证的取得,丰富了公司在体外诊断血型领域产品线的品种,有利于进一步提升公司的核心竞争力和市场拓展能力,对公司未来的经营将产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457438.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","09996","BK0239","BK0077","BK1100","BK0012","BK1574","BK0028","300406","159883","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645009988","title":"每周股票复盘:九强生物(300406)股东终止转让5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2645009988","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645009988?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:44","pubTimestamp":1781984653,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,九强生物报收于11.34元,较上周的11.54元下跌1.73%。本周关注点公司公告汇总:股东终止向中国医药投资转让5.0000003%股份公司公告汇总关于股东终止协议转让部分股份的公告北京九强生物技术股份有限公司股东邹左军、刘希、孙小林与中国医药投资有限公司于2025年12月8日签署《股份转让协议》,拟协议转让公司29,315,433股股份,占公司总股本的5.0000003%。截至2025年12月31日,标的股份未完成过户登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0046","BK0012","300406","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644825670","title":"九强生物(300406)披露股东终止协议转让部分股份公告,6月18日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644825670","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644825670?lang=zh_cn&edition=full","pubTime":"2026-06-18 23:00","pubTimestamp":1781794850,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,九强生物报收于11.34元,较前一交易日上涨0.35%,最新总市值为66.49亿元。公司于近日披露《关于股东终止协议转让部分股份的公告》。公告显示,北京九强生物技术股份有限公司股东邹左军、刘希、孙小林与中国医药投资有限公司于2025年12月8日签署《股份转让协议》,拟协议转让公司29,315,433股股份,占公司总股本的5.0000003%。截至2025年12月31日,标的股份未完成过户登记。根据协议约定,自2026年1月1日起,一方有权解除协议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800043136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0077","BK0046","300406","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641044461","title":"九强生物(300406.SZ):两款产品取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2641044461","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641044461?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:52","pubTimestamp":1780905120,"startTime":"0","endTime":"0","summary":"智通财经APP讯, 九强生物(300406.SZ)发布公告,公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》,涉及产品:“可溶性生长刺激表达基因2蛋白测定试剂盒(胶乳免疫比浊法)”、“全自动凝血分析仪(型号:MDC3600、 MDC2600)”。上述产品医疗器械注册证的取得,丰富了公司在体外诊断生化和凝血分析仪器细分领域产品线的品种,有利于进一步提升公司的核心竞争力和市场拓展能力,对公司未来的经营将产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0012","BK1574","159883","BK0028","BK1583","BK1100","300406","09996","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153266","title":"九强生物(300406.SZ):全自动化学发光免疫分析仪取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153266","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640153266?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:37","pubTimestamp":1780562251,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九强生物(300406.SZ)发布公告,公司于近日收到北京市药品监督管理局颁发的全自动化学发光免疫分析仪(型号Gi3000)《医疗器械注册证》。该产品医疗器械注册证的取得,丰富了公司在体外诊断化学发光细分领域产品线的品种,有利于进一步提升公司的核心竞争力和市场拓展能力,对公司未来的经营将产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1100","300406","BK0028","09996","BK1583","BK0012","BK0239","BK0077","BK1574","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640974736","title":"九强生物(300406.SZ):甲状腺素结合力测定试剂盒取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640974736","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640974736?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:49","pubTimestamp":1780472947,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九强生物(300406.SZ)发布公告,公司于近日收到北京市药品监督管理局颁发的甲状腺素结合力测定试剂盒(磁微粒化学发光免疫分析法)《医疗器械注册证》,该试剂盒用于体外定量测定人血清或血浆中甲状腺素结合力(T-Uptake)。此次医疗器械注册证的取得,丰富了公司在体外诊断化学发光细分领域产品线的品种,有利于进一步提升公司的核心竞争力和市场拓展能力,对公司未来的经营将产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","09996","BK0012","BK1574","BK1583","BK0077","BK0239","BK0028","300406","BK0046","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638943736","title":"九强生物(300406)披露“九强转债”恢复转股提示性公告,5月28日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638943736","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638943736?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:43","pubTimestamp":1779979393,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘,九强生物报收于12.53元,较前一交易日上涨0.16%,最新总市值为73.46亿元。公司于近日披露《关于“九强转债”恢复转股的提示性公告》。公告显示,因实施2025年年度权益分派,“九强转债”自2026年5月21日至权益分派股权登记日暂停转股;根据相关规定,“九强转债”将于股权登记日后的第一个交易日,即2026年5月29日起恢复转股。债券代码为123150,债券简称为九强转债。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0239","300406","BK0077","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638368960","title":"九强生物(300406)披露可转债转股价格调整公告,5月27日股价下跌1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638368960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638368960?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:35","pubTimestamp":1779892518,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘,九强生物报收于12.51元,较前一交易日下跌1.88%,最新总市值为73.35亿元。该股当日开盘12.75元,最高12.8元,最低12.3元,成交额达5559.66万元,换手率为1.05%。本次转股价格调整不涉及送股或资本公积金转增股本等情况,仅因派送现金股利导致。调整后的转股价格自2026年5月29日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700046255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406","BK0012","BK0046","BK0077","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638716538","title":"九强生物:公司2025年年度权益分派股权登记日为","url":"https://stock-news.laohu8.com/highlight/detail?id=2638716538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638716538?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:18","pubTimestamp":1779693505,"startTime":"0","endTime":"0","summary":"证券之星消息,九强生物(300406)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问:你好这都五月底了分红啥时候落实到位九强生物回复:您好,公司2025年年度权益分派股权登记日为:2026年5月28日,除权除息日为:2026年5月29日。具体内容详见公司披露于巨潮资讯网(http://www.cninfo.com.cn)的《2025年年度权益分派实施公告》(公告编号:2026-052)。以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500015081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0012","300406","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637820566","title":"股市必读:九强生物(300406)5月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2637820566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637820566?lang=zh_cn&edition=full","pubTime":"2026-05-21 03:24","pubTimestamp":1779305051,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,九强生物报收于12.83元,下跌1.08%,换手率0.64%,成交量2.73万手,成交额3508.05万元。董秘最新回复投资者: 公司在 2025 年 12 月 9 号公告中国医药投资要承让邹左军、刘希、孙小林合计5%的股份,请问目前该事项交接完毕了吗?请具体回答,不要模棱两可董秘: 您好,相关进展请您关注公司发布的公告内容,感谢您对公司的关注。交易信息汇总资金流向5月20日主力资金净流出298.67万元;游资资金净流出93.63万元;散户资金净流入392.29万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100004342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0012","BK0077","BK0028","BK0239","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636432088","title":"九强生物(300406)披露权益分派期间“九强转债”暂停转股公告,5月20日股价下跌1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636432088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636432088?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:09","pubTimestamp":1779271758,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,九强生物报收于12.83元,较前一交易日下跌1.08%,最新总市值为75.22亿元。该股当日开盘12.92元,最高12.98元,最低12.78元,成交额达3508.05万元,换手率为0.64%。近日,九强生物发布《关于实施权益分派期间“九强转债”暂停转股的提示性公告》。公告显示,公司因实施2025年年度权益分派,根据相关规定,自2026年5月21日起至权益分派股权登记日止,可转换公司债券“九强转债”暂停转股,预计于股权登记日后的第一个交易日恢复转股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","300406","BK0239","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636951832","title":"九强生物(300406)披露2025年年度股东会决议公告,5月19日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636951832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636951832?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:50","pubTimestamp":1779184247,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,九强生物报收于12.97元,较前一交易日上涨0.46%,最新总市值为76.04亿元。该股当日开盘12.9元,最高13.11元,最低12.89元,成交额达4229.54万元,换手率为0.77%。九强生物于近日披露《2025年年度股东会决议公告》。公告显示,公司于2026年5月18日召开2025年年度股东会,会议由董事会召集,董事长邹左军主持,采用现场与网络投票结合方式召开。出席会议股东共133人,代表股份328,155,205股,占公司有表决权股份总数的56.3101%。其中两项议案为特别决议通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0077","300406","BK0028","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786564298326,"stockEarnings":[{"period":"1week","weight":0.0197},{"period":"1month","weight":0.0569},{"period":"3month","weight":-0.0323},{"period":"6month","weight":-0.0286},{"period":"1year","weight":-0.1378},{"period":"ytd","weight":-0.0368}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京九强生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21242人(较上一季度增加18.01%)","perCapita":"19973股","listingDate":"2014-10-30","address":"北京市海淀区花园东路15号旷怡大厦5层","registeredCapital":"58614万元","survey":" 北京九强生物技术股份有限公司的主营业务是体外诊断试剂及体外诊断仪器的生产及销售。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统、液体活检系统。2025年1月14日,公司荣获“军事科学技术进步一等奖”,2025年12月6日,公司凭借高质量的信息披露水平、高效的沟通方式、优异的公共关系管理和投资者关系管理能力,荣获“金信披奖”。","listedPrice":14.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九强生物,300406,九强生物股票,九强生物股票老虎,九强生物股票老虎国际,九强生物行情,九强生物股票行情,九强生物股价,九强生物股市,九强生物股票价格,九强生物股票交易,九强生物股票购买,九强生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}